MoneyMaker Research News - Stocks Tips: Pharma stocks gain

Pharma stocks in Nifty opened on Thursday in a positive note, trading higher by 1.43 percent at 8,738 levels on NSE in the morning hours, with Cadila Healthcare moving the top gainer in the index, by 4.94%.

Divi’s Lab was trading higher by 2.81 percent at Rs 656 per share, also Sun Pharma soared by 2.02% at Rs 478 per share. Lupin was trading up by 1.56%, Aurobindo Pharma higher by 1.25% and Cipla was up by 1.06% among others, while Dr Reddy Laboratoreis’s was the top loser in the index, down by 0.38% at Rs 2,023 per share and Glaxo Smith Kline was trading lower by 0.35% at Rs 2,382 per share.

Meanwhile, the benchmark indices Nifty was trading up by 0.6% at 9,858 levels and Sensex was trading higher by 16 points at 31,583 levels at 10.50 am, today. Indian rupee opened at 64.03 per dollar and was trading at 64.07 per dollar, up 0.07 percent from its last close of 64.11.

Best Stock tips, Active Stocks by Volume, DLF shares surges, IPO Update

Money Maker Research, the Best stock advisory in India, helps traders with most accurate Stock tips and updates for market players.

Shares DLF (Real Estate Company) rose over 7% on Wednesday after company’s announcement that it will hold a board meeting on 25 August to decide on promoters’ proposal to sell their 40 percent stake to GIC in a deal estimated at about Rs 13,000 crore. The stock gained 7.87% to the day’s high of Rs 189.1 on NSE.

Stock Pulse: Benchmark indices were trading in positive terrain while showing marginal slip after morning gains. Nifty still trading over 9,800 level and Sensex still up over 100 points. Shares of Infosys Ltd were topping the charts as most active stocks in terms of value followed by realty stock DLF. Meantime, Nifty PSU Bank is one of the major stocks on NSE, which was trading up by 1.11% at 3,268 level. OBC is the top index gainer trading higher by 2.76% at Rs 122.95 per share.

IPO Subscription: IPO of Apex Frozen Foods got subscribed by 55 percent on its second day of subscription as per NSE data. The total issue volume stands at 62,10,000 shares. Total bids got by the IPO stood at 34,36,080.

Canfin Home Share Future Advice and Technical View for Tomorrow

Research Head (MONEY MAKER RESEARCH & INVESTMENT ADVISOR PVT LTD) is having a view that one can go short in Canfin Home Future.

“Canfin Home Future is the stock which I would recommend to sell below Rs 2700, this can see a slide to levels closer to Rs 2600-2620 zones, keep stop loss above Rs 2800.

Futures of Canfin Home were closed 2.98 per cent down today at Rs 2,711.45 NSE.